Lipella Pharmaceuticals I...

NASDAQ: LIPO · Real-Time Price · USD
0.64
0.00 (0.05%)
At close: Aug 15, 2025, 2:41 PM
0.64
0.00%
After-hours: Aug 15, 2025, 02:41 PM EDT

Lipella Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
129.78M 536.36K 483.53K 104.45M 210.99M 210.85M 210.88M 106.83M 151.01K 184.16K 59.03K 59.03K 208K 259.35K 233.47K 233.47K 84.5K
Cost of Revenue
1.71M 2.55M 2.55M 2.34M 2.73M 2.59M 3.06M 2.88M 2.57M 2.55M 2.44M 2.27M 1.87M 1.46M 1.08M 606.25K 258.33K
Gross Profit
126.87M -3.36M -2.35M 101.83M 208.11M 208.26M 207.82M 103.95M -2.41M -2.36M -2.38M -2.21M -1.67M -1.2M -849.93K -372.78K -173.83K
Operating Income
-1.33B -5.08M -4.36M -4.26M -4.88M -4.75M -4.38M -3.73M -2.94M -2.59M -2.67M -2.48M -2.04M -1.92M -1.48M -952.75K -612.9K
Interest Income
21.34M 64.28K 95.37K 113.75K 141.67K 137.84K 97.17K 64.51K 23.15K 1.68K 1.74K 1.24K 632.00 101.00 n/a n/a n/a
Pretax Income
-1.31B -5.02M -4.26M -4.14M -4.74M -4.62M -4.29M -3.68M -2.93M -2.6M -2.62M -2.43M -1.99M -1.87M -1.48M -956.16K -614.6K
Net Income
-1.31B -5.02M -4.26M -4.14M -4.74M -4.62M -4.29M -3.68M -2.93M -2.59M -2.62M -2.43M -1.99M -1.87M -1.48M -956.16K -614.6K
Selling & General & Admin
465.22M 2M 1.84M 1.97M 2.17M 2.16M 1.79M 1.21M 634.46K 226.19K 286.67K 284.89K 379.8K 718.38K 625.74K 579.97K 439.07K
Research & Development
996.25M 3.61M 3.01M 835.22M 835.61M 835.47M 835.49M 2.89M 2.57M 2.55M 2.44M 2.26M 1.87M 1.46M 1.08M 606.25K 258.33K
Other Expenses
-661.56K -1.5M -1.5M -1.5M -842.6K -811.78K -811.78K -811.78K -811.62K -45 -45 -45 -201 n/a n/a n/a n/a
Operating Expenses
1.46B 2M 2.29M 2.32M 3.47M 3.34M 3M 3.19M 2.39M 2.77M 2.73M 2.54M 2.25M 2.18M 1.71M 1.19M 697.4K
Interest Expense
n/a n/a n/a n/a 5.45K 10.85K 15.55K 17.21K 13.39K 9.61K 6.62K 6.68K 6.75K 6.83K 5.12K 3.41K 1.7K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.46B 5.48M 4.71M 4.52M 5.15M 4.87M 4.53M 3.88M 3.09M 2.77M 2.73M 2.54M 2.25M 2.18M 1.71M 1.19M 697.4K
Income Tax Expense
n/a n/a n/a n/a n/a n/a -1.13K -1.63K -2.39K -2.72K -1.59K -1.09K -330 n/a n/a n/a n/a
Shares Outstanding (Basic)
1.05M 1.05M 1.12M 950.71K 911.55K 816.27K 719.22K 712.35K 702.52K 550.1K 513.23K 483.33K 483.33K 453.7K 479.26K 425.22K 307.3K
Shares Outstanding (Diluted)
1.05M 1.05M 1.12M 950.71K 911.55K 846.32K 719.22K 717.99K 717.99K 550.1K 513.23K 483.33K 483.33K 483.96K 479.26K 425.22K 315.59K
EPS (Basic)
-1.25K -4.96 -4.4 -4.95 -6.1 -6.28 -6.13 -5.68 -5.16 -5.2 -5.33 -5.03 -4.21 -4.63 -3.84 -2.75 -1.95
EPS (Diluted)
-1.25K -4.96 -4.43 -4.98 -6.15 -6.36 -6.18 -5.73 -5.19 -5.2 -5.39 -5.09 -4.27 -4.74 -3.89 -2.8 -2
EBITDA
-1.31B -5.01M -4.26M -4.14M -4.74M -4.61M -4.28M -2.95M -1.42M -359.22K n/a -522.91K -862.76K -1.48M -1.48M -952.75K -612.9K
EBIT
-1.31B -5.02M -4.26M -4.14M -4.74M -4.61M -4.28M -3.67M -2.91M -2.59M -2.61M -2.42M -1.98M -1.86M -1.48M -952.75K -612.9K
Depreciation & Amortization
3.54K 2.89K 2.89K 3.13K 1.58M 1.6M 1.96M 2.67M 1.88M 2.59M 2.67M 2.48M 2.04M 1.92M 1.48M 952.75K 612.9K